These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4081503)

  • 1. [Chemical classification of synthetic progestogens].
    Belaisch J
    Rev Fr Gynecol Obstet; 1985 Jun; 80(6 Pt 2):473-7. PubMed ID: 4081503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Choosing the right synthetic progestogen].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1983 Nov; 11(11):1233-42. PubMed ID: 12312705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacology of progestins].
    Michel G; Kuttenn F
    Rev Prat; 1981 Apr; 31(19):1333-47. PubMed ID: 7233015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New gestagens--advantages and disadvantages].
    Kuhl H
    Ther Umsch; 2001 Sep; 58(9):527-33. PubMed ID: 11594150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of synthetic progestin].
    Kamada M; Irahara M; Aono T
    Nihon Rinsho; 1994 Mar; 52(3):593-9. PubMed ID: 8164355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in new progestagens for oral contraception.
    Eyong E
    IPPF Med Bull; 1987 Apr; 21(2):3-4. PubMed ID: 12268598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthetic progestogens (author's transl)].
    Ghéron G
    Sem Hop; 1981 Oct 8-15; 57(37-38):1515-20. PubMed ID: 6270819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physiological action of progesterone and the pharmacological effects of progestogens--a short review.
    Neumann F
    Postgrad Med J; 1978; 54 Suppl 2():11-24. PubMed ID: 368741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemical aspects of steroidal contraceptives].
    Benoit-guyod J-l
    Chim Ther; 1967; 2(5):383-94. PubMed ID: 12334343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progestogens].
    Irahara M; Matsuzaki T; Kuwahara A; Yasui T
    Nihon Rinsho; 2008 Jan; 66(1):111-6. PubMed ID: 18193550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Receptivity to the sex steroids, physiopathological aspects].
    Bercovici JP
    Contracept Fertil Sex (Paris); 1984 Jun; 12(6):821-7. PubMed ID: 12313177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progesterone and progestins].
    De Lignieres B
    Contracept Fertil Sex (Paris); 1979 Dec; 7(12):931-41. PubMed ID: 12261436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new class of highly active progestagens: 17 alpha-CH2X-substituted gona-4,9(10)-dienes. 58. Steroids].
    Hübner M; Ponsold K; Oettel M; Freund R
    Arzneimittelforschung; 1980; 30(3):401-6. PubMed ID: 7190016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral micronized progesterone.
    de Lignières B
    Clin Ther; 1999 Jan; 21(1):41-60; discussion 1-2. PubMed ID: 10090424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
    Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence on oral contraceptive formulation on carbohydrate and lipid metabolism.
    Adams PW; Godsland I; Melrose J; Niththyananthan R; Oakley NW; Seed M; Wynn V
    J Pharmacother; 1980 May; 3(2):54-63. PubMed ID: 12310374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of progestins.
    Sitruk-Ware R
    Maturitas; 2004 Apr; 47(4):277-83. PubMed ID: 15063480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.